Crinetics Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $399 | $640 | $0 |
Gross Profit | -354 | 166 | -262 | |
EBITDA | -87,027 | -82,030 | -73,055 | -62,396 |
EBIT | -87,797 | -82,783 | -73,529 | -62,658 |
Net Income | -76,828 | -74,055 | -66,930 | -60,097 |
Net Change In Cash | 0 | 399 | 640 | 0 |
Free Cash Flow | -63,351 | -46,572 | -54,188 | -39,450 |
Cash | 317,269 | 302,162 | 395,924 | 54,897 |
Basic Shares | 80,091 | 79,008 | 72,289 | 67,146 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $4,013 | $4,737 | $1,078 | $71 |
Gross Profit | 4,013 | 4,737 | 1,078 | 71 |
EBITDA | -221,510 | -166,899 | -106,780 | -74,005 |
EBIT | -222,608 | -167,882 | -107,702 | -74,953 |
Net Income | -214,529 | -159,954 | -106,719 | -72,864 |
Net Change In Cash | 4,013 | 4,737 | 1,078 | 71 |
Cost of Revenue | 52,761 | |||
Free Cash Flow | -170,995 | -116,861 | -89,024 | -62,213 |
Cash | 54,897 | 32,672 | 200,695 | 93,087 |
Basic Shares | 58,071 | 51,982 | 38,436 | 30,448 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.96 |
2024-06-30 | -$0.94 |
2024-03-31 | -$0.93 |
2023-12-31 | -$0.90 |
